Chemical Compound

Paroxetine Hydrochloride Anhydrous Imp. D (EP); Paroxetine Imp. D (EP); Paroxetine USP Related Compound C; Paroxetine USP RC C; (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)- (9CI); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R-trans)-; Paroxetine Related Compound C (USP); (+)-trans-Paroxetine Hydrochloride; BRL-29679A; USP Paroxetine Hydrochloride Related Compound C; Ph Eur Paroxetine Hydrochloride Impurity D; Paroxetine Related Compound C as Hydrochloride; Paroxetine Hydrochloride Hemihydrate Impurity D as Hydrochloride; Paroxetine Hydrochloride Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride

CAS Registry Number 130855-30-0
返回搜索 申请报价
Paroxetine Hydrochloride Anhydrous Imp. D (EP); Paroxetine Imp. D (EP); Paroxetine USP Related Compound C; Paroxetine USP RC C; (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)- (9CI); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R-trans)-; Paroxetine Related Compound C (USP); (+)-trans-Paroxetine Hydrochloride; BRL-29679A; USP Paroxetine Hydrochloride Related Compound C; Ph Eur Paroxetine Hydrochloride Impurity D; Paroxetine Related Compound C as Hydrochloride; Paroxetine Hydrochloride Hemihydrate Impurity D as Hydrochloride; Paroxetine Hydrochloride Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride 结构式
Primary record

Paroxetine Hydrochloride Anhydrous Imp. D (EP); Paroxetine Imp. D (EP); Paroxetine USP Related Compound C; Paroxetine USP RC C; (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)- (9CI); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R-trans)-; Paroxetine Related Compound C (USP); (+)-trans-Paroxetine Hydrochloride; BRL-29679A; USP Paroxetine Hydrochloride Related Compound C; Ph Eur Paroxetine Hydrochloride Impurity D; Paroxetine Related Compound C as Hydrochloride; Paroxetine Hydrochloride Hemihydrate Impurity D as Hydrochloride; Paroxetine Hydrochloride Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride

库存
4,495 克
纯度
99.3 %
CAS
130855-30-0

化合物标识与属性

CAS
130855-30-0
PubChem CID
18635524
SMILES
C1CNC[C@@H]([C@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl
Canonical SMILES
Cl.Fc1ccc([C@H]2CCNC[C@@H]2COc2ccc3c(c2)OCO3)cc1

名称与同义词

  • ent-Paroxetine Hydrochloride
  • Paroxetine Hcl
  • Paroxetine impurity D
  • 130855-30-0
  • Paroxetine hydrochloride
  • Paroxetine impurity D CRS
  • C19H21ClFNO3
  • E8A4U5DP45
  • UNII-E8A4U5DP45
  • Paroxetine hydrochloride, (+)-
  • Paroxetine EP Impurity D HCl
  • GELRVIPPMNMYGS-SATBOSKTSA-N
  • SCHEMBL6100418
  • (+)-trans-Paroxetine Hydrochloride
  • DTXSID70595337
  • Paroxetine hydrochloride, trans-(+)-
  • MFCD22565990
  • AKOS025401435
  • Paroxetine EP Impurity D (HCl salt)
  • EBC-170083
  • FE22690
  • NE16968
  • AC-16421
  • (3R,4S)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride
  • Paroxetine impurity D CRS (Y0000256)
  • DS-018346
  • (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)me
  • A11904
  • EN300-115519
  • H56876
  • Paroxetine hydrochloride related compound C [USP-RS]
  • (3R,4S)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride
  • Z1489071220
  • (3R-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride
  • PAROXETINE RELATED COMPOUND C (15 MG) ((+)-TRANS-PAROXETINE HYDROCHLORIDE)
  • 78246-49-8
  • (3R,4S)-3-((Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride
  • (3R,4S)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride
  • (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride ((+)-trans-Paroxetine Hydrochloride)
  • 130855-16-2
  • (3R,4S)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride
  • (3R,4S)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine hydrochloride
  • (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl)piperidine hydrochloride
  • (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride
  • (3R,4S)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride
  • trans-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride
  • trans-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride
  • (3R,4S)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine--hydrogen chloride (1/1)
  • Paroxetine Hydrochloride Anhydrous EP Impurity D; Paroxetine Hydrochloride EP Impurity D; Paroxetine Hydrochloride Hemihydrate EP Impurity D
  • Paroxetine Hydrochloride Anhydrous Imp. D (EP); Paroxetine Imp. D (EP); Paroxetine USP Related Compound C; Paroxetine USP RC C; (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)- (9CI); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3R-trans)-; Paroxetine Related Compound C (USP); (+)-trans-Paroxetine Hydrochloride; BRL-29679A; USP Paroxetine Hydrochloride Related Compound C; Ph Eur Paroxetine Hydrochloride Impurity D; Paroxetine Related Compound C as Hydrochloride; Paroxetine Hydrochloride Hemihydrate Impurity D as Hydrochloride; Paroxetine Hydrochloride Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride; Paroxetine Impurity D as Hydrochloride